Arkolith/Insider Trading/RVNC/Form 4

Jordan Erica

Chief Commercial OfficerRevance Therapeutics, Inc. (RVNC) · full profile →Form 4 · filed Apr 17, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$9K
Net Open-Market Flow
-$9K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 16, 2024Sell(S)2K$3.80$9K115K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001479290-24-000074) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML